AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is notassociated with ischemic stroke in a population of German children
Authors: Nowak-Gottl, U Strater, R Kosch, A von Eckardstein, A Schobess, R Luigs, P Nabel, P Vielhaber, H Kurnik, K Junker, R
Citation: U. Nowak-gottl et al., The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is notassociated with ischemic stroke in a population of German children, EUR J HAEMA, 66(1), 2001, pp. 57-62
Foetal growth restriction in children with prothrombotic risk factors
Authors: von Kries, R Junker, R Oberle, D Kosch, A Nowak-Gottl, U
Citation: R. Von Kries et al., Foetal growth restriction in children with prothrombotic risk factors, THROMB HAEM, 86(4), 2001, pp. 1012-1016
Thromboembolism in newborns, infants and children
Authors: Nowak-Gottl, U Kosch, A Schlegel, N
Citation: U. Nowak-gottl et al., Thromboembolism in newborns, infants and children, THROMB HAEM, 86(1), 2001, pp. 464-474
Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors
Authors: Ettingshausen, CE Halimeh, S Kurnik, K Schobess, R Wermes, C Junker, R Kreuz, W Pollmann, H Nowak-Gottl, U
Citation: Ce. Ettingshausen et al., Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors, THROMB HAEM, 85(2), 2001, pp. 218-220
Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system
Authors: Junker, R Kratz, M Neufeld, M Erren, M Nofer, JR Schulte, H Nowak-Gottl, U Assmann, G Wahrburg, U
Citation: R. Junker et al., Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system, THROMB HAEM, 85(2), 2001, pp. 280-286
Thrombotic events revisited in children with acute lymphoblastic leukemia - Impact of concomitant Escherichia coli asparaginase/prednisone administration
Authors: Nowak-Gottl, U Heinecke, A von Kries, R Nurnberger, W Munchow, N Junker, R
Citation: U. Nowak-gottl et al., Thrombotic events revisited in children with acute lymphoblastic leukemia - Impact of concomitant Escherichia coli asparaginase/prednisone administration, THROMB RES, 103(3), 2001, pp. 165-172
Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study
Authors: Nowak-Gottl, U Kotthoff, S Hagemeyer, E Junker, R Kehl, HG Vielhaber, H Kececioglu, D
Citation: U. Nowak-gottl et al., Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study, THROMB RES, 103(2), 2001, pp. 93-101
Aspirin versus low-dose low-molecular-weight heparin: Antithrombotic therapy in pediatric ischemic stroke patients - A prospective follow-up study
Authors: Strater, R Kurnik, K Heller, C Schobess, R Luigs, P Nowak-Gottl, U
Citation: R. Strater et al., Aspirin versus low-dose low-molecular-weight heparin: Antithrombotic therapy in pediatric ischemic stroke patients - A prospective follow-up study, STROKE, 32(11), 2001, pp. 2554-2558
Coagulation parameters
Authors: Nowak-Gottl, U
Citation: U. Nowak-gottl, Coagulation parameters, MONATS KIND, 149(1), 2001, pp. 59-59
Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factorfor congenital heart disease
Authors: Junker, R Kotthoff, S Vielhaber, H Halimeh, S Kosch, A Koch, HG Kassenbohmer, R Heineking, B Nowak-Gottl, U
Citation: R. Junker et al., Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factorfor congenital heart disease, CARDIO RES, 51(2), 2001, pp. 251-254
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors
Authors: Nowak-Gottl, U Junker, R Kreuz, W von Eckardstein, A Kosch, A Nohe, N Schobess, R Ehrenforth, S
Citation: U. Nowak-gottl et al., Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors, BLOOD, 97(4), 2001, pp. 858-862
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)
Authors: Mauz-Korholz, C Junker, R Gobel, U Nowak-Gottl, U
Citation: C. Mauz-korholz et al., Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols), THROMB HAEM, 83(6), 2000, pp. 840-843
Evaluation of lipoprotein(a) and genetic prothrombotic risk factors in patients with recurrent foetal loss
Authors: Nowak-Gottl, U Sonntag, B Junker, R Cirkel, U von Eckardstein, A
Citation: U. Nowak-gottl et al., Evaluation of lipoprotein(a) and genetic prothrombotic risk factors in patients with recurrent foetal loss, THROMB HAEM, 83(2), 2000, pp. 350-351
Linkage disequilibrium of the common mutations 677C -> T and 1298A -> C ofthe human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C -> T, 1068C -> T
Authors: Linnebank, M Homberger, A Nowak-Gottl, U Marquardt, T Harms, E Koch, HG
Citation: M. Linnebank et al., Linkage disequilibrium of the common mutations 677C -> T and 1298A -> C ofthe human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C -> T, 1068C -> T, EUR J PED, 159(6), 2000, pp. 472-473
Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome
Authors: Bokenkamp, A von Kries, R Nowak-Gottl, U Gobel, U Hoyer, PF
Citation: A. Bokenkamp et al., Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome, EUR J PED, 159(1-2), 2000, pp. 44-48
Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: A family study
Authors: Kosch, A Junker, R Kurnik, K Schobess, R Gunther, G Koch, HG Nowak-Gottl, U
Citation: A. Kosch et al., Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: A family study, THROMB RES, 99(6), 2000, pp. 531-537
Symptomatic ischemic stroke in full-term neonates - Role of acquired and genetic prothrombotic risk factors
Authors: Gunther, G Junker, R Strater, R Schobess, R Kurnik, K Kosch, A Nowak-Gottl, U
Citation: G. Gunther et al., Symptomatic ischemic stroke in full-term neonates - Role of acquired and genetic prothrombotic risk factors, STROKE, 31(10), 2000, pp. 2437-2441
Thrombosis in children
Authors: Kosch, A von Kries, R Nowak-Gottl, U
Citation: A. Kosch et al., Thrombosis in children, MONATS KIND, 148(4), 2000, pp. 387-397
Abdominal venous thrombosis in neonates and infants: role of prothromboticrisk factors - a multicentre case-control study
Authors: Heller, C Schobess, R Kurnik, K Junker, R Gunther, G Kreuz, W Nowak-Gottl, U
Citation: C. Heller et al., Abdominal venous thrombosis in neonates and infants: role of prothromboticrisk factors - a multicentre case-control study, BR J HAEM, 111(2), 2000, pp. 534-539
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
Authors: von Depka, M Nowak-Gottl, U Eisert, R Dieterich, C Barthels, M Scharrer, I Ganser, A Ehrenforth, S
Citation: M. Von Depka et al., Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism, BLOOD, 96(10), 2000, pp. 3364-3368
Heterozygous FV R506Q mutation in childhood thrombosis: A possible link tothe plasminogen activator inhibitor-1 (PAI-1) 4G/4G genotype and elevated lipoprotein (a) - Preliminary results of a single centre pilot study
Authors: Junker, R Baumer, R Koch, HG Schettler, CH Weber, D Nowak-Gottl, U
Citation: R. Junker et al., Heterozygous FV R506Q mutation in childhood thrombosis: A possible link tothe plasminogen activator inhibitor-1 (PAI-1) 4G/4G genotype and elevated lipoprotein (a) - Preliminary results of a single centre pilot study, FIBRINOL PR, 13, 1999, pp. 26-29
Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
Authors: Junker, R Koch, HG Auberger, K Munchow, N Ehrenforth, S Nowak-Gottl, U
Citation: R. Junker et al., Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia, ART THROM V, 19(10), 1999, pp. 2568-2572
Hypercoagulable state and graft rejection - is there a link?
Authors: Heidenreich, S Nowak-Gottl, U August, C
Citation: S. Heidenreich et al., Hypercoagulable state and graft rejection - is there a link?, NEPH DIAL T, 14(10), 1999, pp. 2293-2296
Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood
Authors: Ehrenforth, S Junker, R Koch, HG Kreuz, W Munchow, N Scharrer, I Nowak-Gottl, U
Citation: S. Ehrenforth et al., Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood, EUR J PED, 158, 1999, pp. S97-S104
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
Authors: Schobess, R Junker, R Auberger, K Munchow, N Burdach, S Nowak-Gottl, U
Citation: R. Schobess et al., Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation, EUR J PED, 158, 1999, pp. S105-S108
Risultati: 1-25 | 26-42